| Property | Value |
|
has major subject area list
|
Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human
|
|
has minor subject area list
|
Adolescent; Adult; Aged; Case-Control Studies; Humans; Influenza A Virus, H3N2 Subtype; Influenza B virus; Middle Aged; Seasons; United States; Vaccination; Young Adult
|
|
information resource reference
|
Grijalva CG, Feldstein LR, Talbot HK, Aboodi M, Baughman AH, Brown SM, Casey JD, Erickson HL, Exline MC, Files DC, Gibbs KW, Ginde AA, Gong MN, Halasa N, Khan A, Lindsell CJ, Nwosu SK, Peltan ID, Prekker ME, Rice TW, Shapiro NI, Steingrub JS, Stubblefield WB, Tenforde MW, Patel MM, Self WH. Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study. Clin Infect Dis. 2021 10 20; 73(8):1459-1468.
|
|
label
|
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
|